Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-04 Option Award | 2024-06-06 4:25 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 75,000 | $0 | 124,600 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:12 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:34 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:54 pm | N/A 2033-06-13 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:50 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 41,650 | $0 | 77,350 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:06 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:06 pm | N/A 2032-06-14 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:16 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2022-02-25 Option Award | 2022-03-01 5:11 pm | N/A 2032-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 37,500 | $0 | 60,700 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 6:45 pm | N/A 2031-06-15 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 4:25 pm | 2021-06-03 2031-06-03 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 9:01 pm | N/A 2031-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 24,600 | $0 | 39,600 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 12:03 pm | N/A 2030-06-16 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-18 Option Award(A) | 2020-06-03 4:28 pm | N/A 2030-05-17 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 30,000 | $0 | 35,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 5:04 pm | 2020-05-28 2030-05-28 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-20 5:17 pm | N/A 2030-05-17 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 17,500 | $0 | 22,500 (Direct) | View |